Prof Stricker has now taken up the clinical directorship of the Australian Prostate Cancer Research Centre in New South Wales. He is also one of the integral members of the National Prostate Cancer Research Centre Australia-wide. The key areas of research that he is looking into are: A. The use of imaging and improved accuracy […]
Australian Prostate Cancer Research Centre NSW Read More »
Opened late last year by Prime Minister Gillard, The Kinghorn Cancer Centre is a joint venture between the Garvan Institute of Medical Research and St Vincent’s Hospital. Associate Professor Phillip Stricker was appointed Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre. In response to the $5.5 million dollars funding over four years, he
Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre Read More »
The first case of Nanoknife treatment for prostate cancer was performed in late February. Dr Stricker said he was pleased with the outcome and welcomed a leading edge surgical technology that would allow yet another option when tailoring treatments for patients. In particular, he felt that that the Nanoknife procedure coould help minimise side-effects. Nanoknife
Nanoknife – the first case Read More »
Dr Stricker performed just over 250 surgical cases in 2012, one of the largest series in Australasia. When asked about the breakdown between robotic and open, he said that as per previous years over 200 were robotic. Given the outcomes, he believes it wil continue as a favoured choice for surgical treatment. Dr Stricker has
Robotic surgery prevails Read More »
Prime Minister Julia Gillard, Deputy Prime Minister Wayne Swan and Minister for Health Tanya Plibersek announced Sydney would have a new centre of excellence to research and treat prostate cancer. Located in the newly opened Kinghorn Cancer Centre, this new prostate cancer reasearch facility will be a joint initiative between the Garvan Institue, St
World-class prostate research centre for Sydney Read More »
Special thanks to St. Vincent’s Private Hospital for hosting a Big Aussie Barbie and raising over $1,000 for prostate cancer. Several different volunteers showed their support and effort – Urology nurses, Nursing Education managers, Staff from all around the hospital and even staff family members. They even had some Rugby League Greats attend on the
Big Aussie Barbie for Prostate Cancer Read More »
In her article for the Australian Financial Review, Prostate treatment: when less is more, Jill Margo discusses the emergence of a new hybrid treatment for prostate cancer. Focal therapy is about to become available in Australia. It is still controversial, althoguh manhy consider it a welcome alternative to other more invasice treatments.
Focal therapy – less is more Read More »
In her article for the Australian Financial Review, How MRI works for prostate cancer, Jill Margo looks at the advantages of MRI over ultrasound in locating prostate cancer. Dr Phillip Stricker explains how MRI has a higher chance of locating elusive tumours and allows other treatments, such as surgery and radiotherapy, to be performed with
How MRI works for prostate cancer Read More »
In her article for the Australian Financial Review, Bucking the biopsy’s brutal bang, Jill Margo investigates progress made in prostate biopsy. Her interview with Dr Phillip Stricker reveals the latest advances in prostate biopsy, how they came about and what they mean to the patient. Read the article to find out how men can now
Bucking the biopsy’s brutal bang Read More »
All of my patients receive questionnaires to assess their quality-of-life in addition to their cancer outcomes. The results were just presented at the Annual Meeting of the Urological Association of America and won First Prize for this presentation – see poster Click here to download a PDF of this poster.
AUA awards first prize to our presentation. Read More »
St Vincent’s Hospital recently unveiled the latest surgical robot. The da Vinci Si Surgical System, developed by Intuitive Surgical, provides high definition 3D imaging, better instrumentation and greater access to tighter spaces. Already revolutionising treatment Dr Stricker says ‘In the coming months we will be working to analyse surgical outcomes of those who have undergone
New surgical system gives better access Read More »
In a study just published by the British Journal of Urology International, the association between nerve-sparing radical prostatectomy and the risk of increased margins – that is, edges of the removed tumour that show cancer cells – is assessed. Looking at a large cohort of patients who underwent nerve-sparing radical prostatectomy, Dr Moore – a
Nerve sparing surgery – impact on cancer outcome Read More »
In research recently accepted for publication in the British Journal of Urology International, Dr Stricker – as part of a team of Australian health professionals at the Garvan Institute of Medical Research and St Vincents Prostate Cancer Centre – looked at the way in which the type of cancer at the edges of a removed
Gleason Grade – impact on adjunct treatments Read More »
St Vincent’s Prostate Cancer Centre, as Chaired by Dr Phillip Stricker, is one of five international sites to engage in a study to assess the pentafecta. The pentafecta is a new concept used to report outcomes of minimally invasive robotic surgery and was championed by Vip Patel. Traditionally surgeons viewed robotic surgery outcomes in terms
Robotic Surgery – focus now on 5 outcomes Read More »
Safe and accurate biopsies are essential to the management of prostate cancer. Whilst the transrectal biopsy is more common in Australia, transperineal biopsy potentially has a lower risk of infection rate and better detection of anterior-based tumours. As a leader in the care of men with prostate cancer and a world initiator of the transperineal
Biopsy – transperineal versus transrectal Read More »
